| Epigenetic regulation of the BDNF gene: implications for psychiatric disorders F Boulle, DLA Van Den Hove, SB Jakob, BP Rutten, M Hamon, J Van Os, ... Molecular psychiatry 17 (6), 584-596, 2012 | 360 | 2012 |
| Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression MJF Levy, F Boulle, HW Steinbusch, DLA van den Hove, G Kenis, ... Psychopharmacology 235, 2195-2220, 2018 | 321 | 2018 |
| Hippocampal and behavioral dysfunctions in a mouse model of environmental stress: normalization by agomelatine F Boulle, R Massart, E Stragier, E Païzanis, L Zaidan, S Marday, C Gabriel, ... Translational psychiatry 4 (11), e485-e485, 2014 | 104 | 2014 |
| TrkB inhibition as a therapeutic target for CNS-related disorders F Boulle, G Kenis, M Cazorla, M Hamon, HWM Steinbusch, L Lanfumey, ... Progress in neurobiology 98 (2), 197-206, 2012 | 95 | 2012 |
| Developmental fluoxetine exposure increases behavioral despair and alters epigenetic regulation of the hippocampal BDNF gene in adult female offspring F Boulle, JL Pawluski, JR Homberg, B Machiels, Y Kroeze, N Kumar, ... Hormones and behavior 80, 47-57, 2016 | 94 | 2016 |
| Prenatal stress and early‐life exposure to fluoxetine have enduring effects on anxiety and hippocampal BDNF gene expression in adult male offspring F Boulle, JL Pawluski, JR Homberg, B Machiels, Y Kroeze, N Kumar, ... Developmental psychobiology 58 (4), 427-438, 2016 | 93 | 2016 |
| Ethanol-induced epigenetic regulations at the Bdnf gene in C57BL/6J mice E Stragier, R Massart, M Salery, M Hamon, D Geny, V Martin, F Boulle, ... Molecular psychiatry 20 (3), 405-412, 2015 | 70 | 2015 |
| 5-HTT independent effects of fluoxetine on neuroplasticity MJF Levy, F Boulle, MB Emerit, C Poilbout, HWM Steinbusch, ... Scientific Reports 9 (1), 6311, 2019 | 44 | 2019 |
| Long-term consequences of chronic fluoxetine exposure on the expression of myelination-related genes in the rat hippocampus Y Kroeze, D Peeters, F Boulle, DLA Van Den Hove, H Van Bokhoven, ... Translational psychiatry 5 (9), e642-e642, 2015 | 35 | 2015 |
| Behavioral and neurochemical characterization of TrkB-dependent mechanisms of agomelatine in glucocorticoid receptor-impaired mice F Boulle, H Velthuis, K Koedam, HW Steinbusch, DLA van den Hove, ... European Neuropsychopharmacology 26 (1), 65-77, 2016 | 24 | 2016 |
| Anti-Neurodegenerating Activity: Structure–Activity Relationship Analysis of Flavonoids G Preet, A Haj Hasan, P Ramlagan, S Fawdar, F Boulle, M Jaspars Molecules 28 (20), 7188, 2023 | 3 | 2023 |
| Epigenetic regulation of BDNF-TrkB signaling in the pathophysiology and treatment of mood disorders F Boulle | 2 | 2013 |
| Is the effect of fluoxetine on plasticity related to serotonin transporter or tropomyosin-related receptor kinase B? MJF Levy, F Boulle, MB Emerit, HW Steinbusch, D Van den Hove, G Kenis, ... European Neuropsychopharmacology 29, S348, 2019 | | 2019 |
| Effect of fluoxetine and MIML4–11, a novel tropomyosin-related kinase receptor agonist, in a lipopolysaccharide-induced model of depression MJF Levy, F Boulle, VS Martin, C Poilbout, D Rognan, L Lanfumey European Neuropsychopharmacology 25, S292-S293, 2015 | | 2015 |
| Effect of fluoxetine on brain-derived neurotrophic factor-mediated signalling in primary cortical neurons M Levy, E Stragier, MB Emerit, F Boulle, L Lanfumey European Neuropsychopharmacology 25, S15-S15, 2015 | | 2015 |
| The Impact of Fluoxetine Treatment on BDNF Signaling and Cellular Plasticity in the Brain J De Vry, F Boulle, BPF Rutten, DLA van den Hove, J Prickaerts PHARMACOLOGY, MECHANISMS OF ACTION AND POTENTIAL SIDE EFFECTS, 71, 2015 | | 2015 |